MEMO PLUS GOLD: THE GOLD STANDARD IN MEMORY ENHANCEMENT
BACOPA MONNIERA or Brahmi has been investigated in several Indian laboratories for its neuropharmacological effects.
Malhotra and Das (1959) reported a sedative effect of glycosides named hersaponins. Aithal and Sirsi (1961) found that the alcoholic extract, and to a lesser extent, the aqueous extract of the whole plant exhibited tranquilizing effects on albino rats and dogs.
Prakash and Sirsi (1961) on the other hand, have found that the alcoholic extract of the plant and chlorpromazine improved the performance of rats in motor learning. Sinha (1971) has reported that a single dose of the glycoside hersaponin is better than peritobarbitone in facilitating acquisition and retention of brightness discrimination reaction.
It is difficult, however, to interpret these results in the context of the available known traditional claims of improving learning and memory.
Therefore, the evaluation of the traditional claims of Brahmi was initiated by investigating its effect on the acquisition, consolidation and retention of three newly acquired behavioral responses in albino rats. (Singh and Dhawan, 1977, 1982).
In spite of extensive use of Brahmi by the practitioners of Ayurveda, well-designed clinical trials to evaluate its efficacy as a memory enhancing agent have also been conducted.
The safety and tolerability of bacosides in 51 healthy human volunteers were assessed (Asthana, et al. 1996). It was found that single oral doses of 20-200 mg or 100 and 200 mg once daily for 4 weeks were safe and did not produce any reaction or side effect.
Subsequently, placebo-controlled double blind phase II clinical trials in 36 children with Attention Deficit Hyperactivity Disorder (ADHD) were conducted with the Brahmi extract. The children received either a placebo or 50 mg of the extract twice daily for 12 weeks.
The children receiving the extract showed significant improvement in scores of several test systems and there were no side effects (unpublished data of CDRI).
Later, clinical trials were initiated in elderly cases of Age Associated Memory Impairment (AAMI) at 3 medical centers, and 30 patients completed a 16-week study at BRD Medical College, Gorakhpur.
A significant improvement in logical memory, forward digit span and paired associate learning has been observed from the fourth week onward in the group treated with the standardized extract without showing any side effect (CDRI Annual Report, 2000-2001).
Another detailed clinical trial was conducted at the Neuropharmacology Laboratory, Brain Sciences Institute, Swinburne University of Technology in Victoria, Australia in collaboration with the Neuropsychology Laboratory, School of Biophysical Science and Electrical Engineering in Victoria by Nathan et al. (2001).
In this trial, the chronic effects of Brahmi extract on memory function were examined among forty six healthy human subjects aged between 18 to 60 years.
The study was a double-blind placebo-controlled independent group design in which subjects were randomly allocated to one of the two treatment conditions, i.e. Brahmi extract (300 mg) or placebo. Neuropsychological tests were conducted pre-baseline and at 5 and 12 weeks post-drug administration. Brahmi extract significantly improved speed of visual information processing measured by the Inspection Time (IT; Taylor and Creelman 1967), learning rate and memory consolidation measured by Auditory Verbal Learning Test (AVLT; Roy, 1964), and state anxiety examined using Strait-Trait Anxiety Inventory (Spielberger, 1979).
The results of the clinical trial suggested that Brahmi extract improved higher order cognitive processes that are critically dependent on the input of information from our environment such as learning and memory.
Another study to measure the effect of Brahmi extract on human memory was conducted by Roodenrys, et al. (2002). Seventy six adults aged between 40 and 65 years volunteered for the double-blind randomized, placebo-controlled study in which various memory functions were tested and levels of anxiety measured in three testing sessions: one prior to the trial, one after three months on the trial, and one six weeks after the completion of the trial.
The results showed a significant effect of Brahmi on the test for the retention of new information. In the follow-up tests, it was found that the rate of learning was unaffected, suggesting that Brahmi decreases the rate of forgetting newly acquired information.
1. Aithal HN, Sirsi M: Pharmacological investigation on Herpestis monniera. Ind. J. Pharmacy,
1961, 23: 2-5.
2. Asthana OP, Srivastava JS, Ghatak A, Gaur SPS, Dhawan BN: Safety and tolerability of bacosides A and B in healthy human volunteers. Ind. J. Pharmacol. 1996, 28: 37.
3. Bhakuni DS, Dhar ML, Dhar MM, Dhawan BN, Mehrotra BN: Screening of Indian plants for biological activity: Part II. Ind. J. Exptl. Biol., 1969, 7: 250-262.
4. Bhattacharya SK, Ghoshal A: Anxiolytic activity of a standardized extract of Bacopa monniera: An experimental study. Phytomed., 1998, 5: 95-100.
5. Bhattacharya SK, Kumar A, Ghoshal S.: Effect of Bacopa monniera of animal models of Alzheimer's disease and perturbed central markers of cognition in rats. Res. Comm. Pharmacol. Toxicol., 1999, 4: 1-12.
6. Bhattacharya SK, Bhattacharya A, Kumar A, Ghoshal A: Antioxidant activity of Bacopa monniera in rat frontal cortex, striatum and hippocampus. Phytotherap. Res., 2000, 14: 174-179.
7. Chandel RS, Kulshreshtha DK, Rastogi RP: Bacogenin Az: A new sapogenin from Bacopa monniera. Phytochemistry, 1977, 16: 141-143.
8. Chatterjee N, Rastogi RP, Dhar ML: Chemical examination of Bacopa monniera Wettst. Part I: Isolation of chemical constituents. Ind. J. Chem., 1963, 1: 212-215.
9. Chatterjee N, Rastogi RP, Dhar ML: Chemical examination of Bacopa monniera Wetst. Part II: The constitution of bacoside A. Ind. J. Chem., 1965, 3: 24-29.
10. Chopra RN, Nayar SL, Chopra IC: Glossary of Indian Medicinal Plants, New Delhi: Council of Scientific and Industrial Research, 1956: p.32.
11. Cook L and Weidley E: Behavioral effect of some psychopharmacological agents. Ann. NY Acad Sci., 1957, 66: 740-752.
12. Dar A, Channa A: Calcium antagonistic activity of Bacopa monniera on vascular and intestinal smooth muscles of rabbit and guinea pig. J. Ethnopharmacol., 1999, 66: 167-174.
13. Das A, Shanker G, Nath C, Pal R, Singh S and Singh HK: A comparative study in rodents of standardized extracts of Bacopa monniera and Ginkgobiloba: Anticholinestrase and cognitive enhancing activities. Pharmacology, Biochemistry and Behavior, 2002, 73: 893-900.
14. Dash V, Bhagwan, K, Vaidya L: Diagnosis and Treatment of Disease in Ayurveda! Based on Ayurved Sukhyam of Todarananda. Part III, New Delhi, Concept Publishing Company, 1998: p.142.
15. Dhawan BN: Centrally acting agents from Indian plants. In: Koslow SH, Srinivas Murthy R, Coclho V (Eds.): Decade of the Brain: India/USA Research in Mental Health and Neurosciences, Rockville MD, National Institute of Medical Health, 1995, 197-202.
16. Dhawan BN: R&D issues and medical concerns in the development of herbal drugs. In: Wozniak DA, Yuem A, Garett M, Shuman TM (Eds.): Proceedings of International Symposium on Herbal Medicine: A Holistic Approach, San Diego State University, 1997, pp.152-156.
17. Emerich DF, Walsh TJ: Cholinergic cell loss and cognitive impairment following intraventricular and intradentate injections of colchicines. Brain Res., 1999, 517: 157-167.
18. Handa SS: Quality Control: Medicinal Plants and Plant Products, Proceedings of International Workshop on Medicinal Plants: their Bioactivity, Screening & Evaluation. Organized by Center for Science and Technology of the Non-aligned and other Developing countries with the support of United Nations Industrial Development Organization (UNIDO) and Central Drug Research Institute (CSIR), Lucknow, Dec. 2-5, 1997, Manuscript L-22.
19. Jaon P, Khanna NK, Trehan N, Pendse VK, Godhwani JL: Anti-inflammatory effects of an Ayurvedic preparation, Brahmi Rasayana in rodents. Ind. J. Exp. Biol., 1994, 32: 633-636.
20. Kar Chowdhury P, Parmar D, Kakkar P, Shukla R, Seth PK, Srimal RC: Anti-stress effect of bacosides of Bacopa monniera: Modulation of Hsp 70 expression, superoxide dismutase and cytochrome P450 activities in rat brain. Phytother. Res., 2002, 16: 639-645.
21. Kulshreshtha DK, Rastogi RP: Bacogenin A1: A novel dammerane triterpene sapogenin from Bacopa monniera. Phytochemistry, 1973, 12: 887-892.
22. Kulshreshtha DK, Rastogi RP: Bacogenin A2: A new sapogenin from bacosides. Phytochemistry, 1974, 13: 1205-1206.
23. Kumar M, Goel RK: Effect of Rasayanas on gastroduodenal ulcerations and secretion. Ind. J. Pharmacol., 2000, 32: 161.
24. Manjrekar NA: Experimental and clinical evaluation of putative cognitive enhancers, Ph.D. Thesis, University of Bombay, Bombay, 1996.
25. Malhotra CK, Das PK: Pharmacological studies of Herpestis monniera Linn (Brahmi). Ind. J. Med. Res., 1959, 47: 294-305.
26. Pal R, Sarin JPS: Quantitative determination of bacosides by UV-Spectrophotometry. Ind. J. Pharm. Sci., 1992, 54: 17-18.
27. Pal R, Dwivedi AK, Singh A, Kulshreshtha DK: Quantitative determination of bacosides by HPLC. Ind. J. Pharm. Sci., 1996, 60: 328-329.
28. Prakash JC, Sirsi M: Comparative study of the effects of Brahmi (Bacopa monniera) on learning in rats. J. Sci. Indust. Res., 1962, 21: 93-96.
29. Rai D, Bhatia G, Palit G, Pal R, Singh A and Singh HK: Adaptogenic effect of Bacopa monniera (Brahmi). Pharmacology, Biochemistry and Behavior, 2003, (in press).
30. Rastogi A, Mehrotra BN, Kulshreshtha DK: In: Jain SK (Chief Ed.): Proceedings of IV International Congress of Ethnobiology, Nov. 17-21, 1994, Deep Publications, New Delhi, 1996, p.93.
31. Rey A: L'examen clinique psychologie. Presse Universitaires de France, Paris, 1964.
32. Roodenrys A, Booth D, Bulzomi A, Phipps A, Micallef C, Smoker J: Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology, 2002, 27(2): 279-281.
33. Sairam K, Rao CHV, Agarwal VK, Joshi VK, Goel RK: Effect of Bacopa monniera Linn on gastric ulceration and secretion. Ind. J. Pharmacol., 2000, 32: 81.
34. Satyavati GV: Leads from Ayurveda on medicinal plants acting on the nervous system. In: Koslow SH, Srinivasa Murthy R, Coetho GV (Eds.): Decade of the Brain: India/USA Research in Mental Health and Neurosciences, Rockville MD, National Institute of Mental Health , 1995, 185-189.
35. Shanker G, Singh HK: Anxiolytic profile of standardized Brahmi extract. Ind. J. Pharmacol, 2000, 32: 152.
36. Sidman M: Avoidance conditioning with brief shock and no exteroceptive warning signal. Science, 1953, 118: 157-158.
37. Singh HK and Dhawan BN: The effect of Bacopa monniera on the learning ability of rats. Ind. J. Pharmacol., 1978, 10: 72.
38. Singh HK and Dhawan BN: Effect of Bacopa monniera Linn (Brahmi) on the learning ability of rats. 39. Singh HK and Dhawan BN: Neuro-psychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn. (Brahmi). Ind. J. Pharmacol., 1997, 29S: 359-365.
40. Singh HK, Dhawan BN: Drugs affecting learning and memory. In: Tandon PN, Bijlani V, Wadhwa A (Eds.): Lectures in Neurobiology, New Delhi, Wiley Kastern, 1992, 189-202.
41. Singh HK, Rastogi RP, Srimal RC, Dhawan BN: Effect of bacosides A and B on avoidance responses in rats. Phytotherapy Res., 1988, 2: 70-75.
42. Singh HK, Shanker G, Patnaik GK: Neuro-pharmacological and anti-stress effects of bacosides: A memory enhancer. Ind. J. Pharmacol., 1996, 28: 47.
43. Singh HK, Srimal RC, Srivastava AK, Garg NK, Dhawan BN: Neuro-psychopharmacological effects of bacosides A and B. Abstr. IV International Conference of Neurobiology of Learning and memory, Irvine, California, 1990, p.80.
44. Singh HK, Dhawan BN: Effect of a mixture of bacosides A and B on mental retention capacity of rats. Ind. J. Pharmacol., 1985, 17(1): 0-167.
45. Singh HK, Gulati A, Srimal RC, Dhawan BN: Effect of bacosides A & B on EEG changes in rabbits Abstr. VIII Annual Conference of Indian Academy of Neurosciences, Chandigarh, 1989.
46. Singh HK, Srimal RC, Dhawan BN: Effect of bacosides on complex training schedules using negative and positive reinforcements. Abstr. IX Annual Conference of Indian Academy of Neurosciences, Lucknow, 1990.
47. Singh HK, Srimal RC, Dhawan BN: Neuro-psychopharmacological investigations on Bacosides from Bacopa monniera Ethnopharmacologie: Methods, Objectifes: Acetes du ier Colloque Europen d'Ethnopharmacologie, Metz, 1990, 319-322.
48. Singh HK, Srimal RC, Srivastava AK, Garg NK and Dhawan BN: Neuro-psychopharmacological effects of Bacosides A and B. Proceedings of the Fourth Conference on Neurobiology of Learning and Memory, University of California, Irvine, October 17-20, 1990.
49. Singh HK, Dhawan BN: Pre-clinical neuro-psychopharmacological investigations on Bacosides: A nootropic memory enhancer. Update Ayurveda-94, Mumbai, Abstract No.T3:3, 1994.
50. Dhawan BN, Singh HK: Pharmacology of Ayurvedic nootropic Bacopa monniera. World Psychiatric Association: Section Meeting: International Convention o Biological Psychiatry; Theme: Future Mental Health Care & Biological Psychology, Mumbai, Abstract No.NR-59, 1996.
51. Singh HK, Dhawan BN: Improvement of learning and memory by saponins of Bacopa monniera. Canad. J. Physiol. Pharmacol., 1994, 725I: 407.
52. Singh HK, Shanker G and Patnaik GK: Facilitation of memory by bacosides: a naturally occurring saponins. Abstr. III European Pharmacological Colloquium, Genevo (Italy), 1996.
53. Singh A, Singh B, Shanker G and Singh HK: Integration of traditional medicine into modern medicine in India. Abstr. I International Conference of Anthropology and History of Health and Disease, Genova (Italy), 1996.
54. Dhawan BN, Singh HK: Pharmacological studies on Bacopa monniera, an Ayuredic nootropic agent. Europ. Neuropsychopharmacol., 1996, 653: 144.
55. Dhawan BN, Singh HK: Anti-amnesic activity of bacosides, active constituents of Bacopa monniera Linn. Abstr. XXI CINP Congress, Glasgow, 1998.
56. Shukla B, Khanna NK, Godwhani JL: Effect of Brahmi Rasayan on the central nervous system. J. Ethnopharmacol., 1987, 21: 65-74.
57. Pandey GS (Ed): Indian Materia Medica of Shri Bhavmisra C 1500-1600 AD, with a commentary by KC Chunekar, Varanasi, Chaukhambha Bharati Academy, 1984, p.461.
58. Singh RH, Singh BN, Sarkar FH, Udupa KN: Comparative biochemical studies on the effect of four Medhya Rasayan drugs described by Caraka on some central neurotransmitters in normal and stressed rats. J. Res Ind. Med. Yoga Homeo., 1979a, 14: 7-14.
59. Singh RH, Singh L, Sen SP: Studies on the anti-anxiety effect of the Medhya Rasayana drug Bahmi (Bacopa monniera Linn) - Part II (experimental studies). J. Res. Ind. Med. Yoga Homeo., 1979b, 14: 1-6.
60. Singh RH, Singh L: Studies on the anti-anxiety effect of the Medhya Rasayana drug Brahmi (Bacopa monniera Wettst) - Part I. J. Res. Ayurveda Sidha, 1980, 1: 133-148. 61. Singh RH, Sinha BN: Brahmi versus Mandukparni: A study on the identification of two different Medhya Rasayana drugs. J. Res. Ind. Med. Yoga Homeo, 1978, 13: 65-68.
62. Sinha MM: Some empirical behavioral data indicative of concomitant biochemical reactions. Proceed Ind. Sci. Congress Part II, Banglore, 1971, 1-26.
63. Spielberger CD : Understanding Stress and Anxiety, Harper and Row, New York, 1979.
64. Stough C, Lloyad J, Clarke J, Downey L, Hutchison CW, Rodgers T, Nathan P: The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology, 2001, Published online: DOI 10. 1007/s 0021301 00815, 1-8.
65. Takahashi M, Sugaya K, Kubota K: Kangen Karyu prevents the decrease of cholinergic markers following nucleus basalis magnocellularis lesions. Jap J. Pharmacol., 1992, 60: 307-310.
66. Taylor M, Creelman T: PEST: Efficient estimate on prohibitory function. J. Aoust Soc. Am., 1967, 41: 782-787.
67. Tripathi YB, Chaurasia A, Tripathi E, Upadhya A, Dubey GP: Bacopa monniera Linn as an antioxidant: Mechanism of action. Ind. J. Exp. Biol., 1966, 34: 521-526.
68. Vohora SB, Khanna T, Athar M, Ahmad B: Analgesic activity of bacosine, a new triterpine isolated from Bacopa monniera. Fitoterap., 1997, 68: 361-365.